Valuation: Mecure Industries PLC

Market Cap 380B 275M 241M 222M 208M 391M 25.97B 399M 2.67B 1.03B 12.83B 1.03B 1.01B 44.5B P/E 2024
23.9x
P/E 2025 40.4x
Enterprise Value 428B 311M 272M 251M 235M 441M 29.31B 450M 3.02B 1.17B 14.48B 1.17B 1.14B 50.23B EV / Sales 2024
1.99x
EV / Sales 2025 3.99x
Free-Float
35.41%
Yield 2024
1.08%
Yield 2025 0.49%
3 months+54.31%
6 months+45.55%
Current year+45.55%
1 week 94.9
Extreme 94.9
94.9
1 month 94.9
Extreme 94.9
94.9
Current year 54.55
Extreme 54.55
104
1 year 11.2
Extreme 11.2
104
3 years 5.73
Extreme 5.73
104
5 years 5.73
Extreme 5.73
104
10 years 5.73
Extreme 5.73
104
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+754.95% - 275M
+2.56%+12.99%+63.21%+13.78% 318B
-0.92%+9.59%+30.45%-4.55% 72.22B
+3.20%+9.35%+42.70%+115.15% 8.89B
-0.43%+0.43%+2.99%-6.70% 8.25B
-6.43%-4.71%-9.79%-0.60% 4.23B
-6.42%+5.27%+2.08%+22.34% 3.58B
-6.87%-12.75%-34.90%+19.59% 3.23B
+4.67%+5.54%+50.13%+54.13% 2.72B
-4.41%+5.98%+9.57%-22.65% 2.03B
Average -1.50%+2.50%+91.14%+21.17% 42.32B
Weighted average by Cap. +1.66%+11.47%+54.13%+12.44%

Financials

2024 2025
Net sales 46.03B 33.38M 29.26M 26.97M 25.25M 47.35M 3.15B 48.34M 324M 125M 1.56B 125M 123M 5.4B 77.69B 56.34M 49.4M 45.53M 42.63M 79.93M 5.31B 81.59M 547M 212M 2.63B 212M 207M 9.11B
Net income 2.33B 1.69M 1.48M 1.36M 1.28M 2.4M 159M 2.45M 16.4M 6.35M 78.72M 6.34M 6.2M 273M 6.46B 4.69M 4.11M 3.79M 3.55M 6.65M 442M 6.79M 45.52M 17.61M 218M 17.6M 17.21M 758M
Net Debt 35.77B 25.94M 22.74M 20.96M 19.63M 36.8M 2.45B 37.57M 252M 97.49M 1.21B 97.4M 95.27M 4.19B 48.85B 35.42M 31.06M 28.63M 26.8M 50.26M 3.34B 51.31M 344M 133M 1.65B 133M 130M 5.73B
Logo Mecure Industries PLC
Mecure Industries Plc is a human therapeutics company. The Company is principally in the business of manufacturing drugs, such as tablets, capsules and syrups in Nigeria under two categories namely pharmaceuticals and nutraceuticals. The Company’s Pharmaceuticals segment comprises of over 41 drugs, such as Ebu 200 and 400 (ibuprofen tablets), Laclox, Lamox (an amoxicillin formulation) and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consist of approximately 100 products, including multivitamins and dietary supplements. Its products and services include acute ailment medication, chronic ailment medication, nutraceuticals, multivitamins and a planned expansion into chemotherapy medication. It also offers mobile applications, such as the Smart Pill and Smart Buy applications. These applications serve as online pharmacies that facilitate easy purchase and delivery of Company’s products to retail customers in urban cities.
Employees
195
Date Price Change Volume
26-06-26 NGN 94.90 0.00% 23,862
26-06-25 NGN 94.90 0.00% 236,443
26-06-24 NGN 94.90 0.00% 265,269
26-06-23 NGN 94.90 0.00% 32,220
26-06-22 NGN 94.90 0.00% 90,472
  1. Stock Market
  2. Stocks
  3. MECURE Stock